In 2024, over 230,000 people are projected to be diagnosed with lung cancer, and more than 125,000 will lose their lives to the disease. With high mortality rates, early detection through screenings is essential for improving treatment outcomes and survival.… <a href="https://t.co/cqQxvGJWoT&quot; target="_blank">https://t.co/cqQxvGJWoT</a&gt;

In 2024, over 230,000 people are projected to be diagnosed with lung cancer, and more than 125,000 will lose their lives to the disease. With such high mortality rates, early detection through screenings is essential for improving treatment outcomes and survival. <a href='https://www.linkedin.com/feed/hashtag/?keywords=LungCancerAwareness&hig…; target='_blank'>#LungCancerAwareness</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=LungCancerAwarenessMont…; target='_blank'>#LungCancerAwarenessMonth</a>​

Curious about career opportunities at AtriCure? If you're in the Cincinnati area, don’t miss the chance to meet our recruiters in person! Join us at the Cincinnati All Professions & Diversity Career Fair on Wednesday, November 6th, from 9:00 AM to 12:00 PM at the Cooper Creek Event Center in Blue Ash. We look forward to seeing you there!​
​
Apply early at: <a href="https://okt.to/bkRlsA&quot; target="_blank">https://okt.to/bkRlsA</a&gt;

Built with advanced cryoablation technology, cryoSPHERE® MAX provides a non-opioid, long-lasting solution for post-operative pain relief. ​

Learn how cryoSPHERE MAX is optimizing procedure efficiency &amp; enhancing patient outcomes: <a href="https://t.co/NpBEgUXLnV&quot; target="_blank">https://t.co/NpBEgUXLnV</a&gt;​
<a href="https://twitter.com/hashtag/cryoNB?src=hashtag_click&quot; target="_blank">#cryoNB</a> <a href="https://twitter.com/hashtag/PainManagement?src=hashtag_click&quot; target="_blank">#PainManagement</a>

Built with advanced cryoablation technology, cryoSPHERE® MAX provides a non-opioid, long-lasting solution for post-operative pain relief. ​

Learn how cryoSPHERE MAX is optimizing procedure efficiency and enhancing patient outcomes:​ okt.to/pSYrQ4
<a href='https://www.linkedin.com/feed/hashtag/?keywords=cryoNB&highlightedUpdat…; target='_blank'>#cryoNB</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=PainManagement&highligh…; target='_blank'>#PainManagement</a>

Heart failure is the leading cause of death in Afib patients, but it doesn’t have to be.​
​
Join Dr. Richard Whitlock as he discusses how restoring Normal Sinus Rhythm (NSR) can improve quality of life and survival outcomes for Afib patients.​
​
Discover more about effective Afib treatment at actagainstafib.com.​
​
<a href='https://www.linkedin.com/feed/hashtag/?keywords=Afib&highlightedUpdateU…; target='_blank'>#Afib</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=cardiology&highlightedU…; target='_blank'>#cardiology</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=cardiacsurgery&highligh…; target='_blank'>#cardiacsurgery</a>

During Native American Heritage Month, we honor and celebrate the rich histories, cultures, and contributions of Native American and Indigenous peoples. At AtriCure, we are committed to fostering diversity and inclusivity in all that we do. Join us in recognizing the vibrant heritage and history that continues to shape our shared future. <a href='https://www.linkedin.com/feed/hashtag/?keywords=NativeAmericanHeritageM…; target='_blank'>#NativeAmericanHeritageMonth</a>

An eventful week announcing strong Q3 results &amp; an energized All-Employee Meeting. Grateful to Dr. David Newton for sharing insights on cardiac care, his hybrid program success <a href="https://twitter.com/myMemorial&quot; target="_blank">@myMemorial</a>, &amp; the future of hybrid therapy. <a href="https://twitter.com/hashtag/HybridTherapy?src=hashtag_click&quot; target="_blank">#HybridTherapy</a> <a href="https://twitter.com/hashtag/Electrophysiology?src=hashtag_click&quot; target="_blank">#Electrophysiology</a>

The new AtriClip® FLEX-Mini™ Device offers surgeons the same one-handed deployment capability we know works well while excluding the left atrial appendage with a closed-ended deployment.​
​
Learn more: <a href="https://t.co/m3ddhL3wkO&quot; target="_blank">https://t.co/m3ddhL3wkO</a&gt;

The new AtriClip® FLEX-Mini™ Device offers surgeons the same one-handed deployment capability we know works well while excluding the left atrial appendage with a closed-ended deployment.​
​
Learn more: <a href="https://okt.to/akgrvc&quot; target="_blank">https://okt.to/akgrvc</a&gt;